Skip to Content
Alexa Could Diagnose Alzheimer’s and Other Brain Conditions, Should it? image

Alexa Could Diagnose Alzheimer’s and Other Brain Conditions, Should it?: Digital personal assistants could be equipped to diagnose cognitive issues using speech, though the ethics are debatable.

Joanna Thompson quoting David A. Simon (Research Fellow in Digital Home Health)
Inverse

IT’S AN INCREASINGLY common experience: You wander into the kitchen, quietly muttering under your breath, when you hear a disembodied feminine voice say, “I’m…

Call for Applications: Research Fellow for the Project on Psychedelics Law and Regulation (POPLAR) image

Apply now! Call for Applications: Research Fellow for the Project on Psychedelics Law and Regulation (POPLAR), Petrie-Flom Center, Harvard Law School

Deadline: Filled.

Overview The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is hiring a full-time postdoctoral fellow to support its newly launched Project on Psychedelics Law…

 2020 Petrie-Flom Center Annual Conference image

Podcasts now available! 2020 Petrie-Flom Center Annual Conference: Innovation and Protection: The Future of Medical Device Regulation

May 8, 2020

Notice of Revision In light of developments with COVID-19, we converted our annual conference into a series of podcasts interviewing our contributors.Check out the episodes on This Week in…

Artificial Intelligence and Disability/Dependency image

Artificial Intelligence and Disability/Dependency: Equity, Access, and Interdependence

March 24, 2020
Watch Videos

Online Viewing Couldn't join us for the live webstream? Join the conversation on Twitter with #AIanddisability, and check out the speakers' slide presentations below! You can also watch the…

Private Funding of Drug Discovery: Ethical Issues, Practical Alternatives image

Private Funding of Drug Discovery: Ethical Issues, Practical Alternatives: A Health Policy and Bioethics Consortium

March 13, 2020

Description The traditional model for drug development begins with publicly-funded science based in academic or government laboratories before private investors and for-profit pharmaceutical manufacturers become involved with their substantial expertise…

First Opinion: Do large pharma companies provide drug development innovation? image

First Opinion: Do large pharma companies provide drug development innovation?: Our analysis says no

Emily H. Jung (former intern), Alfred Engelberg, and Aaron S. Kesselheim
STAT

From the article: Large pharmaceutical companies oppose legislation being considered by Congress to lower the prices of prescription drugs. Reducing their revenues, they contend, will reduce their investment in drug…

Eighth Annual Health Law Year in P/Review image

Eighth Annual Health Law Year in P/Review

December 6, 2019
Watch Videos

At the Petrie-Flom Center's eighth annual Health Law Year in P/Review, leading experts discussed major developments in health law and policy during 2019 and what to watch out for…

2020 President’s Innovation Challenge, Harvard Innovation Labs

Deadline: January 02, 2020

From the website: The President’s Innovation Challenge is a call to action for Harvard students passionate about developing ideas that make a difference. It celebrates what we can…

Research Associate (Health Care), The Institute for Strategy and Competitiveness, Harvard Business School

Deadline: Open until filled.
Applicants should not reach out to Professor Porter directly.
>Read the full job posting and apply online!

Duties & Responsibilities The Institute for Strategy and Competitiveness (www.isc.hbs.edu) is a joint Institute of Harvard University and Harvard Business School, dedicated to supporting and extending the…

Grants

W. Nicholson Price (Academic Fellow Alumnus)
Berkeley Technology Law Journal

From the abstract: Innovation is a primary source of economic growth and is accordingly the target of substantial academic and government attention. Grants are a key tool in the government…

Genome Editing: Rights and Wrongs: A Health Policy and Bioethics Consortium

March 8, 2019

Gene-editing technologies offer substantial promise in treating disease, but their use raises important ethical and public health questions about how these innovations should be applied and regulated. Different groups have…

Accelerating Alternatives to Animal Experimentation

March 1, 2019

This panel gave an overview of the current state of developing alternatives to animal use in science and research, before then discussing whether an “accelerator” type business model…

Call to Action: Harvard University President’s Innovation Challenge, Harvard Innovation Labs

Deadline: January 02, 2019
>Read full call

From the opportunity: The President’s Innovation Challenge is a call to action, innovation and entrepreneurship. It’s a challenge to the entire Harvard community of students…

Drug Pricing Policies in the United States and Globally: From Development to Delivery

October 24, 2018
Watch Videos

Couldn't join us? Check out the conversation on Twitter: @PetrieFlom #drugpricing and some of our speakers' slide presentations below! Description This one-day conference explored the current pharmaceutical pricing landscape…

Achieving Equitable Access to Vaccines: From Policies to Provisions

October 17, 2018

Description In order to achieve the objectives of global health organization policies those policies must be translated into actionable provisions and agreements. The Global Healthcare Innovation Alliance Accelerator endeavors to…

New Funding Frontiers: Innovative Funding Models in Translational Research

October 1, 2018

The working group briefing book is available now for download. Description This one-day working group and conference explored the challenges in pursuing for-profit private funding for early stage translational research.…

The Petrie-Flom Center and Edmond J. Safra Center for Ethics Fellow-in-Residence, Petrie-Flom Center, Harvard Law School, and Edmond J. Safra Center, Harvard University

Deadline: November 15, 2018

Each year the Edmond J. Safra Center for Ethics at Harvard University hosts several fellows-in-residence. For 2019-20, they are concentrating their fellowships on the Ethics of Technological…

Petrie-Flom Center and Edmond J. Safra Center for Ethics Fellow-in-Residence: The Ethics of Technological and Biomedical Innovation

Petrie-Flom Center

Each year the Edmond J. Safra Center for Ethics at Harvard University hosts several fellows-in-residence. For 2019-20, they are concentrating their fellowships on the Ethics of Technological and Biomedical Innovation. …

Administering Health Innovation

Rachel E. Sachs (Academic Fellow Alumna)
Cardozo Law Review

From the article: Scholars and policymakers have recently begun to focus on the role federal agencies charged with health-related missions can play in the development of innovative health technologies and…

Drug Approval in a Learning Health System

W. Nicholson Price (Academic Fellow Alumnus)
Minnesota Law Review, Forthcoming

From the article: The current system of FDA approval seems to make few happy. Some argue FDA approves drugs too slowly; others too quickly. Many agree that FDA—and…

Moratoria and Innovation in the Reproductive Sciences: Of Pretext, Permanence, Transparency, and Timelimits

Russell Spivak, I. Glenn Cohen (Faculty Director) and Eli Y. Adashi
Journal of Health & Biomedical Law

From the abstract: As progress in the biosciences soldiers forth, new breakthroughs can often be swept up in a common narrative, that is, the narrative of science as a disruptive…

Health Insurance’s Secondary Cost Problem: Market and Mandatory Solutions to Balance Billing and Other Symptoms

Matthew J.B. Lawrence (Academic Fellow Alumnus)
Harvard Law & Policy Review

From the abstract: This Article identifies a fundamental problem with health insurance and, so, contemporary American health care. While competition pushes health insurers to minimize the primary costs of their…

Circumvention Medical Tourism and Cutting Edge Medicine: The Case of Mitochondrial Replacement Therapy

I. Glenn Cohen (Faculty Director)
Indiana Journal of Global Legal Studies

From the article: “Medical Tourism” is the travel of patients from a home country to a destination country for the primary purpose of receiving health care. “Circumvention…

Sources and Consequences of High Drug Prices in the US: A Health Policy and Bioethics Consortium

May 11, 2018

Description High drug costs reduce patient adherence and lead to worse outcomes. The process for translating a drug's price, set by the manufacturer, to cost paid by patients and…

Harvard Medical School Annual Bioethics Conference 2018: Defining Death: Organ Transplantation and the 50-Year Legacy of the Harvard Report on Brain Death

April 11 - 13, 2018

The 2018 Annual Bioethics Conference explored the legacy of the 1968 report from the Harvard Medical School committee that proposed the concept of “brain death” as a new criterion for…

Diseases of Despair: The Role of Policy and Law

April 12 - 13, 2018

Description Anne Case and Angus Deaton shocked the world with their 2015 report that noted an increase in all-cause mortality among middle-aged white non-Hispanic men and women in the United States.…

CSPC 2018: Building Bridges Between Science, Policy, and Society, Canadian Science Policy Centre

Deadline: April 23, 2018
>Read full call

Overview The Canadian Science Policy Centre announces the call for panel proposals for the 10th Canadian Science Policy Conference (CSPC) to be held in Ottawa, Ontario, …

Petrie-Flom Center launches Project on Precision Medicine, Artificial Intelligence, and the Law

Q & A with I. Glenn Cohen (Faculty Director)
Harvard Law Today

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen…

The Petrie-Flom Center Launches the Innovative Funding Models in Translational Research Project

The Petrie-Flom Center

January 30, 2018 - The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is launching the Innovative Funding Models in Translational Research Project to explore the bioethical,…

Future Directions for Laboratory Animal Law in the United States: Pre-Workshop Webcast and Workshop

January 26, 2018
Watch Videos

Video of the full event will be posted here soon! Want updates sent to your inbox? Sign up for our newsletter! Couldn't join us in person for the January 26…

Call for Applications: Research Fellow for Diagnostic Digital Home Health image

Apply now! Call for Applications: Research Fellow for Diagnostic Digital Home Health, Petrie-Flom Center, Harvard Law School

Deadline: Filled.

Overview The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is hiring a full-time post-doctoral fellow to support its newly launched Diagnostic Digital Home Health…

Research Fellow for Precision Medicine image

Research Fellow for Precision Medicine, Petrie-Flom Center, Harvard Law School

Deadline: Position has been filled.

Duties & Responsibilities This is a newly created full-time term appointment for a post-doctoral employee needed to support the work of the Petrie-Flom Center on a sponsored research project in…

The Petrie-Flom Center Launches New Project: Precision Medicine, Artificial Intelligence, and the Law (PMAIL)

Petrie-Flom Center

The Project on Precision Medicine, Artificial Intelligence, and the Law will seek to better understand the frontiers of big data in health care diagnostics, through interdisciplinary analysis of important health…

It’s time to levy penalties for failing to report clinical trial results

Holly Fernandez Lynch (Academic Fellow Alumna and former Executive Director)
STAT

From the article: I started my first job as an attorney in the fall of 2007, days after President George W. Bush signed the Food and Drug Administration Amendments Act (FDAAA)…

Postdoc in Economics and Management of Innovation, University of Copenhagen

Deadline: February 15, 2018
Karin Beukel

>Read full call

The Unit for Innovation, Entrepreneurship and Management, Department of Food and Resource Economics (IFRO), Faculty of Science at the University of Copenhagen is offering a 3-year position for a postdoc…

Call for PhD Applications, Collaborative Research Programme in Biomedical Innovation Law (CeBIL), University of Copenhagen

Deadline: Open until filled.
Timo Minssen, Director of CeBIL

>Read full call

About the programme Supported by a research grant of DKK 35 million from the Novo Nordisk Foundation, the  Collaborative Research Programme in Biomedical Innovation Law (CeBIL) will address and…

Sixth Annual Health Law Year in P/Review

December 12, 2017
Watch Videos

Couldn't join us? Check out the conversation on Twitter: @PetrieFlom #healthlawpreview2018 and some of our speakers' slide presentations below! Description The Sixth Annual Health Law Year in P/Review…

Health Law Workshop: Rachel E. Sachs

December 4, 2017

Presentation Topic: "Delinking Reimbursement" This paper is not available for download. To request a copy in preparation for the workshop, please contact Jennifer Minnich at jminnich@law.harvard.edu. About…

Call for Applications: President’s Innovation Challenge, Harvard Innovation Labs

Deadline: January 02, 2018

>Read full call

This opportunity is only open to Harvard students. We are pleased to announce the seventh annual President’s Innovation Challenge for entrepreneurship. Hosted by the Harvard Innovation…

HLS in the World: New Technologies, New Dilemmas: Part of the HLS200 Bicentennial Celebration

October 27, 2017
Watch Videos

This event was part of the HLS in the World sessions of HLS │200, a bicentennial summit of academic sessions and programs devoted to legal issues of pressing importance. Panel Description …

Fourth Annual Harvard-UCLA Food Law and Policy Conference: Food Innovation and the Law: Navigating the Next Frontier

October 13, 2017

The Food Law Lab at Harvard Law School and the Resnick Program for Food Law & Policy at UCLA School of Law hosted the 4th Annual Harvard-UCLA Food Law and…

Mobile Health Innovation and Interagency Coordination

Rachel E. Sachs (Academic Fellow Alumna)
Annals of Health Law

From the paper: An app that can tell when a phone’s owner is having a seizure.1 A device that transforms a phone into a mobile EKG machine.2 An…

The Cost of Medications: Current Realities and the Future of Pharmaceutical Pricing Regulations in the United States

October 4, 2017
Watch Videos

From “Pharma Bro” Martin Shkreli to huge price jumps for the EpiPen to the Hepatitis C treatment that costs $1000 per pill, pharmaceutical pricing is a major issue in…

Health Law Workshop: William M. Sage

September 11, 2017

Presentation Download the Presentation: "Fracking Health Care: The Need to Safely De-Medicalize America and Recover Trapped Value for Its People" About the Presenter William M. Sage is James R. Dougherty…

Critical Pathways to Improved Care for Serious Illness: Concluding Convening

June 23, 2017

Download the Report "Toward a Serious Illness Program Design & Implementation Framework" from the roundtables! Couldn't join us for the event? Check out the slide presentation below! At this…

Trying to Keep up with the Health Care Debate on the Hill? Follow These Folks on Twitter

Megha Satyanarayana, featuring Rachel E. Sachs (Academic Fellow Alumna)
STAT News

From the article: The GOP effort to repeal and replace Obamacare is picking up steam again as the Senate works on its bill behind closed doors. How to keep track…

(Health) Law and Order

Mumu Xu, interviewing Rachel E. Sachs (Academic Fellow Alumna)
Beyond the Microscope Podcast

We’ve got a special episode today for all you STEM/legal nerds. Our guest is Rachel Sachs, an Associate Professor at the Washington University in St. Louis School…

Sanofi, Regeneron ask court to shield Dupixent from Amgen patent attack

Tracy Staton, citing blog post by Rachel E. Sachs (Academic Fellow Alumna)
FiercePharma

From the article: [...]Amgen has caught fire for its aggressive stance on its PCSK9 patents, which also protect its own drug in the class, Repatha. Market watchers note that a…

Health Law Workshop: Kathryn Zeiler

March 27, 2017

Presentation Topic: "Communication-And-Resolution Programs: The Numbers Don’t Add Up" This paper is not available for download. To request a copy in preparation for the workshop, please contact Jennifer…

Regulating Black-Box Medicine

W. Nicholson Price II (Academic Fellow Alumnus)
Michigan Law Review

From the abstract: Data drive modern medicine. And our tools to analyze those data are growing ever more powerful. As health data are collected in greater and greater amounts, sophisticated…

Critical Pathways to Improved Care for Serious Illness

March 10, 2017

This discussion continued at a second roundtable event on June 23, 2017. Learn more on the website! Download the Report "Toward a Serious Illness Program Design & Implementation Framework" from the two…

Research Associate - Healthcare, Harvard Business School

Deadline: Open until filled.
>Read full posting

Duties & Responsibilities The Research Associate works directly with Professor Michael Porter as one of his principal, full-time research associates. The role will focus almost exclusively on Professor Porter…

Health Law Workshop: Brendan Maher

February 13, 2017

About the Presenter Brendan S. Maher is a Professor of Law and the Director of the independently endowed Insurance Law Center at UConn School of Law. A graduate of Stanford…

Looking Forward: The Next Generation of Biosimilars

February 7, 2017
Watch Videos

Couldn't make it to the event? Check out some of the speakers' slides below! Description Many of today’s important medications are biological products made from living organisms,…

Regulating Secrecy

W. Nicholson Price II (Academic Fellow Alumnus)
Washington Law Review

Abstract: Inventors face a stark choice between two intellectual property systems of protecting innovative ideas: patents and trade secrecy. But accounts of this choice underexplore the role of the regulators…

Promoting healthcare innovation on the demand side

W. Nicholson Price II (Academic Fellow Alumnus) and Rebecca S. Eisenberg
Journal of Law and the Biosciences

Abstract: Innovation policy often focuses on fortifying the incentives of firms that develop and sell new products by offering them lucrative rights to exclude competitors from the market. Regulators also…

Federal Circuit Court Appeal Cites Rachel E. Sachs

Paul D. Clement et al., citing work by Rachel E. Sachs (Academic Fellow Alumna)
U.S. Court of Appeals for the Federal Circuit

No. 17-1480 UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT AMGEN INC., AMGEN MANUFACTURING, LTD., and AMGEN USA, INC., Plaintiffs-Appellees, v. SANOFI, SANOFI-AVENTIS U.S. LLC, AVENTISUB LLC, f…

Regeneron CEO: Amgen’s disruptive Praluent-blocking patent move hurts patients

Carly Helfand, quoting Rachel E. Sachs (Academic Fellow Alumna)
FiercePharma

From the article: Now, Regeneron and Sanofi will ask the Federal Circuit “to quickly review if we can have a stay, and frankly, the merits of the entire case…

Could Amgen’s Patent Victory Be Bad For Medicine?

Matthew Herper, quoting Rachel E. Sachs (Academic Fellow Alumna)
Forbes

From the article: Last night, in a nearly unprecedented move, a federal judge ordered a cholesterol medicine that is on the market and used by patients to be withdrawn because…

President-Elect Trump’s Health Policy Agenda: Priorities, Strategies, and Predictions

December 19, 2016
Watch Videos

The Petrie-Flom Center hosted a live web panel to address what health care reform might look like under President-elect Trump's administration. Expert panelists discussed the future of the Affordable…

Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Matt Richtel and Andrew Pollack, quoting Rachel E. Sachs (Academic Fellow alumna)
New York Times

From the article: Rachel Sachs, an associate law professor at Washington University in St. Louis and expert in innovation policy, said the government had every right to seek price concessions.…

The Hope and Hype of Precision Medicine: A Health Policy and Bioethics Consortium

November 16, 2016

Description There has been considerable hype surrounding personalized and precision medicine in the past few years-including President Obama's 2015 announcement of $215 million for the Precision Medicine Initiative. While some policymakers…

Health Care after the Election

October 24, 2016
Watch Videos

Looking for more on this topic now that the election has been decided? Check out our 5th Annual Health Law Year in P/Review on January 23, 2017. At this full-day event,…

PFC Spotlight: Academic Fellow Alumnus Michael Frakes

Petrie-Flom Center

Michael Frakes was an Academic Fellow from 2009-2011, during which time he researched deterrence and medical malpractice law, culminating in a publication in the University of Chicago Law Review. Today,…

Health Law Workshop: W. Nicholson Price II

October 17, 2016

Presentation Topic: "Regulating Black-Box Medicine" This paper is not available for download. To request a copy in preparation for the workshop, please contact Jennifer Minnich at jminnich@law.harvard.edu. …

President’s Innovation Challenge, Harvard Innovation Lab

Deadline: December 5, 2016
>Read full call

General Description: We are pleased to announce the sixth annual President's Innovation Challenge for entrepreneurship. Hosted by the Harvard Innovation Labs, the Challenge amplifies the creativity, diversity,…

Health Law Workshop: Patricia J. Zettler

September 12, 2016

Presentation Download the Presentation: Pharmaceutical Federalism About the Presenter Patricia J. Zettler is associate professor of law at Georgia State University College of Law. She has expertise in the regulation…

5 reasons why no one has built a better EpiPen

Meghana Keshavan, quoting W. Nicholson Price II (Academic Fellow Alumnus)
STAT

[...] But critics say Mylan has little incentive to improve EpiPens: “If you’re the monopolist, and you’ve got a product that expires every year, and it…

The Coalition to Transform Advanced Care (C-TAC) Launches Service Affiliate C-TAC Innovations,: Which Includes Respecting Choices®

The Coalition to Transform Care (C-TAC) is the Petrie-Flom Center's partner in the Project on Advanced Care and Health Policy, launched in March 2016. La Crosse, WI - C-TAC expands…

Federal Government’s Proposed Expansion of Regulation of Biospecimen Research Should Be Reconsidered: New Commentary from Petrie-Flom Fellowship Alumnus Christopher T. Robertson

Christopher T. Robertson and Jonathan D. Loe
Biopreservation and Biobanking

Note: The full article is behind a paywall. Abstract: In September, the U.S. Department of Health and Human Services, together with other federal agencies, announced proposed changes to the…

Health Insurance as Innovation Incentive

Amy Monahan, reviewing paper by Rachel E. Sachs (Academic Fellow)
Jotwell

Excerpt from the article: In Prizing Insurance: Prescription Drug Insurance as Innovation Incentive, Rachel Sachs brings together the often disparate worlds of intellectual property theory and health insurance design, to…

Balancing the Surgeon’s Responsibility to Individuals and Society

Bruce D. White and Luke C. Gelinas (Clinical Research Ethics Fellow)
Springer

From the chapter in The SAGES Manual, Ethics of Surgical Innovation: 18. Balancing the Surgeon’s Responsibility to Individuals and Society Cutting-edge and progressive physicians and surgeons innovate. Indeed, innovation…

Prizing Insurance: Prescription Drug Insurance as Innovation Incentive,: New Article from Academic Fellow Rachel E. Sachs

Rachel E. Sachs
Harvard Journal of Law and Technology

Abstract: A problem perennially facing scholars of both intellectual property and health law is the need to incentivize appropriately the development of new pharmaceuticals. Although physicians have an arsenal of…

Promoting Healthcare Innovation on the Demand Side

Rebecca Eisenberg and W. Nicholson Price II (Academic Fellow Alumnus)
U of Michigan Law & Econ Research Paper No. 16-008; U of Michigan Public Law Research Paper No. 503

Abstract: Innovation policy often focuses on the incentives of firms that sell new products. But optimal use of healthcare products also requires good information about the likely effects of products…

Book Review: FDA in the Twenty-First Century:The Challenges of Regulating Drugs and New Technologies

Ryan Abbot, reviewing book edited by Holly Fernandez Lynch (Executive Director) and I. Glenn Cohen (Faculty Director)
Journal of Law and the Biosciences

From the review: FDA in the 21st Century is an excellent edited volume based on the Petrie–Flom Center's 2013 Annual Conference. The conference sought to gather thought leaders…

Academic Fellow Alumnus W.Nicholson Price II to Join Faculty at University of Michigan School of Law

Petrie-Flom Center

We are pleased to announce that Petrie-Flom Center Academic Fellow Alumnus W. Nicholson Price II has been appointed an Assistant Professor at the University of Michigan School of Law. Nicholson…

The Future of Health Law and Policy: The Petrie-Flom Center’s 10th Anniversary Conference Celebration

March 29, 2016
Watch Videos

The Petrie-Flom Center celebrated its first decade and kicked off the next by looking at the future of health law and policy! The Center brought together Petrie-Flom and other prominent…

Health Law Workshop: Michael Frakes

March 7, 2016

Presentation Download the Presentation (two files): "Does Medical Malpractice Law Improve Health Care Quality?" and Appendix About the Presenter In Spring 2016, Michael Frakes was an Associate Professor of Law at…

Negotiating for Health: The Role of Negotiation and Dispute Resolution in Healthcare

February 27, 2016

Harvard Negotiation Law Review Presents its 21st Annual Symposium Agenda Overview Keynote Address: Dr. Leonard Marcus, Founding Director of the Program for Health Care Negotiation and Conflict Resolution at the…

New Journal of Law & Biosciences featuring Harvard student work

Journal of Law and the Biosciences (JLB)

The Journal of Law and the Biosciences, the open-access journal launched in 2014 by the Petrie-Flom Center and Harvard Law School in partnership with Duke University and Stanford University, has published…

Assessing the Viability of FDA’s Biosimilars Pathway

February 18, 2016
Watch Videos

Couldn't attend the event? Check out some of our speakers' slide presentations! Description The 2010 passage of the Biologics Price Competition and Innovation Act was intended to create a pathway…

Academic Fellow Rachel E. Sachs to Join Faculty at Washington University School of Law

Petrie-Flom Center

We are pleased to announce that Petrie-Flom Center Academic Fellow Rachel E. Sachs has been appointed an Associate Professor at the Washington University in St. Louis School of Law. At…

Fourth Annual Health Law Year in P/Review

January 29, 2016
Watch Videos

Couldn't attend in person? Learn more about the event: Learn more about the presentations - check out select speakers' slides below! Check out the collaborative blog series on the…

A Conversation with Margaret A. Hamburg, FDA Commissioner 2009-2015

January 20, 2016
Watch Videos

Description The Petrie-Flom Center hosted a conversation with former FDA Commissioner (and former New York City Health Commissioner), Dr. Margaret A. Hamburg, led by Peter Barton Hutt, former Chief Counsel…

Why Preventing Cancer Is Not the Priority in Drug Development

Austin Frakt, citing Ben Roin (former Academic Fellow and Faculty Co-Director)
The Upshot, New York Times

From the article: Most people would agree that it would be better to prevent cancer, if we could, than to treat it once it developed. Yet economic incentives encourage researchers…

Innovations in Health Law and Policy: Regulatory Challenges and Strategies for Change Conference: at UNH School of Law

W. Nicholson Price II (Academic Fellow Alumnus)
UNH School of Law

Innovations in Health Law and Policy: Regulatory Challenges and Strategies for Change When: Monday, October 26, 2015 Where: UNH School of Law 2 White Street Concord, New Hampshire Presented by the Health Law…

Heidi Williams wins MacArthur “genius grant”

Peter Dizikes, on Heidi Williams (Student Fellow Alumna)
MIT News

From the article: MIT economist Heidi Williams, whose scholarly work looks at the effects of patent policies and technology on medical research and health care, has been granted a 2015 MacArthur…

Big Data, Patents, and the Future of Medicine

W. Nicholson Price II (Academic Fellow Alumnus)
Cardozo Law Review, Forthcoming

Abstract: Big data has tremendous potential to improve health care. Unfortunately, intellectual property law isn’t ready to support that leap. In the next wave of data-driven medicine, black-box…

At the Frontier: The Ethics of Innovative Surgery: A Neuroethics Seminar Series Event

September 10, 2015
Watch Videos

All modern surgical techniques were once new, so the ethics of surgical innovation is not a new topic. But as our understanding of the brain advances, so does our ability…

Review of Innovation Law and Policy: Preserving the Future of Personalized Medicine: by Rachel Sachs

Lisa Ouellette
Written Description Blog

From the review: I highly recommend two recently posted articles on declining innovation incentives for diagnostic tests, particularly due to changes in patentable subject matter doctrine. In Innovation Law and…

Will clinical trial data disclosure reduce incentives to develop new uses of drugs?

W Nicholson Price II (Academic Fellow alumnus) & Timo Minssen (past Visiting Scholar)
Nature Biotechnology

Petrie-Flom Academic Fellow alumnus Nicholson Price, now an Assistant Professor at the University of New Hampshire School of Law, and past Visiting Scholar Timo Minnsen, Associate Professor at the University…

Countdown to Cures

Stephanie Sutton, quoting Rachel Sachs (Academic Fellow)
The Medicine Maker

From the article: [...] According to Rachel Sachs, an academic fellow at the Petrie-Flom Center at Harvard Law School who has been following the Act with interest, 21st Century Cures has…

Innovation Law and Policy: Preserving the Future of Personalized Medicine

Rachel E. Sachs
U. C. Davis Law Review

Academic Fellow Rachel E. Sachs has a new article forthcoming in 2016 on law and the future of personalized medicine. From the article: Personalized medicine is the future of health care,…

Health Law Workshop: Rachel E. Sachs

April 13, 2015

Presentation Topic: "Rethinking the Incentives/Access Dichotomy: Prescription Drug Reimbursement as Innovation Incentive." This paper is not available for download. To request a copy, please contact Jennifer Minnich at jminnich…

FDA’s Impact on Pharmaceutical Innovation: A lecture by Neil Flanzraich

April 14, 2015
Watch Videos

Neil Flanzraich, Chairman and CEO of Cantex Pharmaceuticals, Inc., discussed the balance between speed and safety in FDA’s regulation of pharmaceutical products. Topics included how FDA’s…

Academic Fellow Rachel Sachs Presents at 2015 Works-in-Progress in Intellectual Property Colloquium

Petrie-Flom Center

Petrie-Flom Academic Fellow Rachel Sachs presented her paper, "Innovation Law and Policy: Preserving the Future of Personalized Medicine," at the 2015 Works-in-Progress in Intellectual Property (WIPIP) Colloquium. Held this year on…

Third Annual Health Law Year in P/Review collaborative blogging with Health Affairs

Petrie-Flom

The Third Annual Health Law Year in P/Review was a big success! Video will be posted on our website shortly, but our presenters will be posting on their respective…

Clinical Trial Recruitment: Problems, Misconceptions, and Possible Solutions,: A Conference

Petrie-Flom Center

On January 19 - 21, 2015, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Regulatory Foundations, Ethics, and Law Program of Harvard Catalyst | The Harvard…

Third Annual Health Law Year in P/Review

January 30, 2015
Watch Videos

Couldn't make it in person? Check out the individual sessions in the videos linked above and the collaborative blog series on the Health Affairs Blog (links below)! The Third…